Citi Credit Research Sees Opportunity in Valeant (VRX), Initiates With Overweight Rating (MNK) (ENDP)
Go back to Citi Credit Research Sees Opportunity in Valeant (VRX), Initiates With Overweight Rating (MNK) (ENDP)| ENDO INTERNAT (NASDAQ: ENDP) | Delayed: 0.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $63.71 | |||
| Open | $0.02 | 52 Week Low | $12.56 | |||
| Day High | $0.29 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $0.00 | |||
| Volume | 24,300 | |||||
| MALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) | Delayed: 0.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $85.83 | |||
| Open | $30.62 | 52 Week Low | $50.90 | |||
| Day High | $0.34 | P/E | 0.34 | |||
| Day Low | $0.34 | EPS | $1.00 | |||
| Volume | 84 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||

